Dr. Rakesh Magun, M.B.B.S
NPI: 1396298055
Total Payments
$1,993
2024 Payments
$407.46
Companies
16
Transactions
68
Medicare Patients
872
Medicare Billing
$122,861
Payment Breakdown by Category
Food & Beverage$1,993 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,993 | 65 | 100.0% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$1,993
65 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $540.86 | 16 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $319.83 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $197.03 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $193.87 | 7 | $0 (2021) |
| Amgen Inc. | $159.50 | 3 | $0 (2023) |
| Eisai Inc. | $156.64 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $86.15 | 2 | $0 (2022) |
| Lundbeck LLC | $82.61 | 5 | $0 (2024) |
| Lilly USA, LLC | $80.76 | 4 | $0 (2024) |
| PFIZER INC. | $62.68 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $407.46 | 15 | Eisai Inc. ($156.64) |
| 2023 | $668.41 | 22 | ABBVIE INC. ($268.47) |
| 2022 | $460.26 | 17 | IMPEL PHARMACEUTICALS INC. ($149.57) |
| 2021 | $456.47 | 14 | Biohaven Pharmaceuticals, Inc. ($193.87) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.93 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Central Nervous System | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: NEUROLOGY | ||||||
| 05/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Central Nervous System | ||||||
| 05/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN | ||||||
| 04/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: PAIN | ||||||
| 04/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Obesity | ||||||
| 03/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neurology | ||||||
| 01/02/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Central Nervous System | ||||||
| 12/27/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PAIN | ||||||
| 12/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Obesity | ||||||
| 12/11/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Neurology | ||||||
| 12/06/2023 | Azurity Pharmaceuticals, Inc. | Eprontia (Drug) | Food and Beverage | Cash or cash equivalent | $21.81 | General |
| Category: epilepsy and migraine | ||||||
| 11/21/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: NEUROLOGY | ||||||
| 10/13/2023 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PAIN | ||||||
| 09/26/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Central Nervous System | ||||||
| 08/22/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Neuroscience | ||||||
| 07/18/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 249 | 326 | $99,482 | $34,205 |
| 2022 | 4 | 242 | 318 | $97,486 | $32,894 |
| 2021 | 6 | 257 | 335 | $103,475 | $37,512 |
| 2020 | 3 | 124 | 160 | $54,361 | $18,250 |
Total Patients
872
Total Services
1,139
Medicare Billing
$122,861
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 82 | $42,148 | $10,295 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 112 | $16,851 | $10,116 | 60.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 101 | $26,563 | $9,332 | 35.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 15 | $10,335 | $2,414 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,585 | $2,048 | 57.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 97 | 99 | $50,886 | $14,403 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 112 | $29,456 | $8,604 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 93 | $13,994 | $8,591 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,150 | $1,296 | 41.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 86 | 89 | $45,746 | $13,753 | 30.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 71 | 111 | $29,193 | $8,949 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 85 | $12,428 | $8,202 | 66.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 21 | $4,040 | $2,541 | 62.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $3,800 | $2,109 | 55.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 12 | $8,268 | $1,958 | 23.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 52 | 56 | $28,784 | $8,863 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 48 | 79 | $20,777 | $6,521 | 31.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 25 | $4,800 | $2,867 | 59.7% |
About Dr. Rakesh Magun, M.B.B.S
Dr. Rakesh Magun, M.B.B.S is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1396298055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rakesh Magun, M.B.B.S has received a total of $1,993 in payments from pharmaceutical and medical device companies, with $407.46 received in 2024. These payments were reported across 68 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,993).
As a Medicare-enrolled provider, Magun has provided services to 872 Medicare beneficiaries, totaling 1,139 services with total Medicare billing of $122,861. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Buffalo, NY
- Active Since 07/29/2016
- Last Updated 04/29/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1396298055
Products in Payments
- UBRELVY (Drug) $349.49
- NURTEC ODT (Drug) $328.46
- Trudhesa (Drug) $319.83
- BOTOX (Biological) $211.36
- AJOVY (Biological) $174.77
- Aimovig (Biological) $159.50
- Leqembi (Drug) $156.64
- VYEPTI (Biological) $82.61
- EMGALITY (Drug) $80.76
- Wegovy (Drug) $40.20
- Austedo XR (Drug) $22.26
- Eprontia (Drug) $21.81
- ONZETRA XSAIL (Drug) $16.61
- ZAVZPRET (Drug) $14.24
- ZEMBRACE SYMTOUCH (Drug) $14.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Student in an Organized Health Care Education/Training Program $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Student in an Organized Health Care Education/Training Program $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Student in an Organized Health Care Education/Training Program $31,872
Paola Ghione, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,368
Student in an Organized Health Care Education/Training Program $20,368
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Student in an Organized Health Care Education/Training Program $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842
Student in an Organized Health Care Education/Training Program $13,842